Proposing a standardized assessment of COVID-19 vaccine-associated cutaneous reactions - 14/12/22
Doi : 10.1016/j.jaad.2022.05.011
Rhea Singh, BS a, b, Rowanne Ali, BS a, c, Sonya Prasad, BS a, d, Steven T. Chen, MD, MPH, MHPEd a, Kimberly Blumenthal, MD, MSc e, Esther E. Freeman, MD, PhD a, f, ⁎ 
a Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
b Virginia Commonwealth University School of Medicine, Richmond, Virginia
c The George Washington University School of Medicine, Washinton, DC
d Icahn School of Medicine, The Mount Sinai Hospital, New York City, New York
e Division of Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
f Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts
∗Correspondence to: Esther E. Freeman, MD, PhD, Department of Dermatology, Massachusetts General Hospital, 50 Staniford St, Boston, MA 02114Department of DermatologyMassachusetts General Hospital50 Staniford StBostonMA02114
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Key words : adverse reactions, COVID-19, dermatology, grading scale, SARS-CoV-2, severity, vaccines
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2022
Publié par Elsevier Masson SAS.
Vol 88 - N° 1
P. 237-241 - janvier 2023 Retour au numéro
Article précédent
- Management of juvenile-onset systemic sclerosis with systemic immunosuppressive therapies: An evidence-based review
- Abrahim Abduelmula, Brian D. Rankin, Nadia J. Luca, Vimal H. Prajapati
- Combination of acitretin and narrowband UV-B for the treatment of vitiligo: A new treatment modality with an impact on tissue E-cadherin expression
- Shahira Ramadan, Ola Abu Zeid, Samia Esmat, Noha Adly Saleh, Magda Assaf, Rana Fathy Hilal
Bienvenue sur EM-consulte, la référence des professionnels de santé.